EURACTIV Greek pharma innovation faces bleak future, industry wants ‘urgent changes’ [Advocacy Lab]
Clawbacks, discontinued therapies, delays, lay-offs and disinvestment have created a concerning pharma business environment in Greece, industry has warned
Clawbacks, discontinued therapies, delays, lay-offs and disinvestment have created a concerning pharma business environment in Greece, industry has warned